+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Qvarspray"

Qvarspray - API Insight, 2022 - Product Thumbnail Image

Qvarspray - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Qvarspray- Drug Insight, 2019 - Product Thumbnail Image

Qvarspray- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Qvarspray is a type of respiratory drug used to treat asthma and other respiratory conditions. It is a combination of two active ingredients, beclomethasone dipropionate and formoterol fumarate dihydrate, which work together to reduce inflammation and open up the airways. Qvarspray is administered via an inhaler and is available in both metered-dose and dry powder inhalers. It is used to treat both acute and chronic asthma, as well as other respiratory conditions such as chronic obstructive pulmonary disease (COPD). Qvarspray is a popular choice for treating asthma and other respiratory conditions due to its effectiveness and convenience. It is a long-acting medication, meaning it can provide relief for up to 12 hours. It is also easy to use and can be taken with or without food. Some companies in the Qvarspray market include GlaxoSmithKline, Merck, and Teva Pharmaceuticals. These companies produce and distribute Qvarspray inhalers and other related products. Show Less Read more